← Leaderboards
Michael Tymianski
Toronto Western Hospital
$5,212,704
Attributed
$5,212,704
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,212,704 · 3
By mechanism
U01$3,771,814 · 1
R01$1,440,890 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Stroke”
- Judith S Hochman · New York University School Of Medicine$100,533,713
- Joseph Paul Broderick · University Of Cincinnati$91,227,021
- Merit E Cudkowicz · Massachusetts General Hospital$58,780,575
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Marinella Temprosa · George Washington University$56,125,420
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$53,611,126
Research focus
StrokeNeuronsPeptidesProtein Protein InteractionProteinsNeuroprotectionAffectBrainPresynaptic Density Protein 95AnimalsRattusIschemiaInvestigationBaseFutureIn VitroClinical TrialsIn VivoNervous System DisorderAlteplaseDrug TargetingArteriesBrain TissueAntihypertensive Agents
Grant awards (11)
Development of a next-generation PSD95 Inhibitor for the treatment of acute ische$846,905
U01 · FY2017 · NS · contact PI
Development of a next-generation PSD95 Inhibitor for the treatment of acute ische$1,198,933
U01 · FY2016 · NS · contact PI
Development of a next-generation PSD95 Inhibitor for the treatment of acute ische$1,152,717
U01 · FY2015 · NS · contact PI
Development of a next-generation PSD95 Inhibitor for the treatment of acute ische$573,259
U01 · FY2014 · NS · contact PI
Targeting PSD Proteins in the Treatment of CNS Injury$233,300
R01 · FY2008 · NS · contact PI
Targeting PSD Proteins in the Treatment of CNS Injury$233,300
R01 · FY2007 · NS · contact PI
Targeting PSD Proteins in the Treatment of CNS Injury$240,268
R01 · FY2006 · NS · contact PI
Targeting PSD Proteins in the Treatment of CNS Injury$246,050
R01 · FY2005 · NS
Targeting PSD Proteins in the Treatment of CNS Injury$248,050
R01 · FY2004 · NS
MOLECULAR MECHANISMS OF CALCIUM-DEPENDENT EXCITOTOXICITY$121,734
R01 · FY2001 · NS
MOLECULAR MECHANISMS OF CALCIUM-DEPENDENT EXCITOTOXICITY$118,188
R01 · FY2000 · NS